- Home
- CCEL vs CNVS Comparison
CCEL vs CNVS Comparison
Compare CCEL & CNVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- CNVS
- Stock Information
- Founded
- CCEL 1989
- CNVS 2000
- Country
- CCEL United States
- CNVS United States
- Employees
- CCEL N/A
- CNVS N/A
- Industry
- CCEL Managed Health Care
- CNVS Consumer Electronics/Video Chains
- Sector
- CCEL Health Care
- CNVS Consumer Discretionary
- Exchange
- CCEL Nasdaq
- CNVS Nasdaq
- Market Cap
- CCEL 34.8M
- CNVS 102.4M
- IPO Year
- CCEL 1997
- CNVS 2003
- Fundamental
- Price
- CCEL $4.41
- CNVS $3.27
- Analyst Decision
- CCEL Strong Buy
- CNVS Buy
- Analyst Count
- CCEL 1
- CNVS 1
- Target Price
- CCEL $8.50
- CNVS $10.00
- AVG Volume (30 Days)
- CCEL 25.6K
- CNVS 383.1K
- Earning Date
- CCEL 10-14-2025
- CNVS 11-13-2025
- Dividend Yield
- CCEL 13.41%
- CNVS N/A
- EPS Growth
- CCEL N/A
- CNVS N/A
- EPS
- CCEL N/A
- CNVS 0.13
- Revenue
- CCEL $31,988,783.00
- CNVS $80,173,000.00
- Revenue This Year
- CCEL $1.75
- CNVS $1.28
- Revenue Next Year
- CCEL N/A
- CNVS N/A
- P/E Ratio
- CCEL N/A
- CNVS $24.78
- Revenue Growth
- CCEL 1.10
- CNVS 77.07
- 52 Week Low
- CCEL $4.09
- CNVS $0.79
- 52 Week High
- CCEL $9.43
- CNVS $7.39
- Technical
- Relative Strength Index (RSI)
- CCEL 45.18
- CNVS 28.84
- Support Level
- CCEL $4.26
- CNVS $3.29
- Resistance Level
- CCEL $4.70
- CNVS $3.91
- Average True Range (ATR)
- CCEL 0.21
- CNVS 0.26
- MACD
- CCEL 0.00
- CNVS -0.06
- Stochastic Oscillator
- CCEL 33.87
- CNVS 3.27
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
About CNVS Cineverse Corp.
Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.